Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5P30CA016086-41
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01AI132178-05
Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV
National Institutes of Health
Grant: 5T32AI007151-42
Infectious Disease Pathogenesis Research Training Program
National Institutes of Health
Grant: 1F32AI152296-01A1
Defining viral and immune mechanisms of Dengue virus serotype 2 immune evasion
NIAID NIH HHS
Grant: F32 AI152296
NCI NIH HHS
Grant: P30 CA016086
NIAID NIH HHS
Grant: R01 AI132178
NIAID NIH HHS
Grant: T32 AI007151
Fields of Study
Keywords
Sustainable Development Goals